VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 76 filers reported holding VAXCYTE INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $525 | +2.1% | 10,300 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $514 | +15.0% | 10,300 | -14.2% | 0.00% | +100.0% |
| Q1 2023 | $447 | +134.0% | 12,000 | +200.0% | 0.00% | 0.0% |
| Q4 2022 | $191 | -99.8% | 4,000 | -21.6% | 0.00% | – |
| Q1 2022 | $123,000 | +1.7% | 5,100 | 0.0% | 0.00% | – |
| Q4 2021 | $121,000 | -6.2% | 5,100 | 0.0% | 0.00% | – |
| Q3 2021 | $129,000 | +13.2% | 5,100 | 0.0% | 0.00% | – |
| Q2 2021 | $114,000 | +26.7% | 5,100 | +10.9% | 0.00% | – |
| Q1 2021 | $90,000 | -26.2% | 4,600 | 0.0% | 0.00% | – |
| Q4 2020 | $122,000 | -46.3% | 4,600 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $227,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management | 22,227 | $439,000 | 0.50% |